The market size value per capita for opacifying preparation for X-ray and diagnostic reagents in Canada has seen fluctuations over the past decade. In 2023, it stood at approximately $6.42 per capita. Analyzing the year-on-year variation from 2022-2023, there was a minor decrease. The five-year CAGR (2018-2023) highlights a general decline with an average yearly decrease.
Future trends to watch for include technological advancements in diagnostic imaging, potential regulatory changes, and Canada's aging population, which may influence demand. Additionally, any post-pandemic adjustments in healthcare priorities could impact market dynamics.
| # | 24 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 9.87 | 2023 | View data | ||
| 2 | 2 Italy | 9.66 | 2023 | View data | ||
| 3 | 3 Greece | 8.33 | 2023 | View data | ||
| 4 | 4 Australia | 7.28 | 2023 | View data | ||
| 5 | 5 Austria | 6.83 | 2023 | View data | ||
| 6 | 6 Canada | 6.42 | 2023 | |||
| 7 | 7 Slovakia | 5.92 | 2023 | View data | ||
| 8 | 8 Spain | 5.61 | 2023 | View data | ||
